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ABSTRACT  TO study  the  in vivo  processing and  secretion  of Apolipoprotein  A-I  (Apo  A-I), 
young chickens were administered  individual  L-[3H]amino acids intravenously and the time of 
intracellular transport of nascent Apo A-I from rough endoplasmic reticulum  (RER) to the Golgi 
apparatus was measured. Within 3 to 9 min there was maximal incorporation  of radioactivity 
into  Apo  A-I  in  both  the  RER  and  the  Golgi  cell  fractions.  By  contrast,  the  majority  of 
radioactive albumin was also present in the RER by 3 to 9 rain, but did not reach peak amounts 
in the Golgi fraction  until 9 to 25 min. Both radioactive Apo A-I and albumin  appeared in the 
blood at about the same time (between  20 and 30 min). NH2-terminal amino acid sequence 
analysis of nascent intracellular  Apo A-I showed that it contains a pro-hexapeptide  extension 
identical  to that of human Apo A-I. After 30 rain of administration  of radioactive amino acids 
radioactive  Apo  A-I  was  isolated by  immunoprecipitation  from  the  liver  and  serum. NH2- 
terminal  sequence analysis of 20 amino acids indicated  that chicken  liver contained  an equal 
mixture of nascent pro-Apo A-I and fully processed Apo A-I, whereas the serum only contained 
processed Apo A-I. Further studies showed that the RER only contained  pro-Apo A-I, whereas 
a mixture  of  pro-Apo A-I  and  processed Apo A-I  was found  in  the  Golgi  complex.  These 
results indicate  that,  in chicken  hepatocytes, there is a more rapid transport of Apo A-I than 
of albumin  from the  RER to the Golgi  cell fractions,  and that Apo A-I  remains in the  Golgi 
apparatus for a longer  period  of time before  it is secreted into the blood.  In addition these 
studies show that the in vivo proteolytic processing of chicken  pro-Apo A-I to Apo A-I occurs 
in the Golgi cell fractions. 
Apolipoprotein A-I (Apo A-I)  t is the major protein compo- 
nent of plasma high density lipoprotein (HDL). It is a single 
polypeptide chain consisting of-234-243 amino acid resi- 
dues (2, 6, 21, 25). The structure of plasma Apo A-I has been 
well studied (8,  11,  17,  18, 20, 22,  35) but the details of its 
biosynthesis and secretion are still not clear. In human, and 
most  other species,  Apo A-I  synthesis is thought to  occur 
mainly in the liver and intestine (8, 14, 18, 20, 22, 35), but in 
avians Apo A-I synthesis also occurs in tissues such as breast, 
~Abbreviations  used  in  this paper.  Apo A-l,  apolipoprotein A-l; 
HDL, high density lipoprotein; PMSF, phenylmethylsulfonyl  fluo- 
ride; RER, rough endoplasmic reticulum; TPCK, N-tosyl-L-phenyl- 
alanine chloromethyl ketone. 
muscle, and kidney (5, 32). Various aspects of  the biosynthesis 
of Apo A-I in these tissues have recently been investigated (3, 
5, 18, 19, 32). Apo A-I, obtained from human intestinal cells 
in organ culture, occurs as several isoforms, suggesting that it 
is initially secreted as a basic precursor which is subsequently 
processed to the more acidic isoproteins found in plasma (39). 
Gel electrophoretic analysis of  the translation products of  Apo 
A-I  mRNA demonstrated that Apo A-I is synthesized as a 
larger  precursor (5,  7,  15,  28,  33,  37,  40).  NH2-terminal 
sequence analysis of  the in vitro-synthesized Apo A-I showed 
that it contains a  24-amino acid NH2-terminal polypeptide 
extension (15). Co-translational cleavage of the in vitro prod- 
uct by ascites and dog pancreas microsomal membranes (16, 
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prepeptide and that the following hexapeptide is akin to the 
propeptides seen in several  secretory polypeptide hormones. 
However the propeptide contains carboxy-terminal gin-gin 
residues and  the  prosegment is  not  cleaved intracellularly 
either by  human  liver and  intestine  in  organ  culture,  by 
perfused rat intestine and  liver,  or by rat hepatocytes and 
human hepatoma cells in culture (12,  13,  16, 38, 39, 41). 
Nascent apolipoproteins are complexed intracellularly with 
lipids prior to secretion into the blood. The site of synthesis 
of  the apoprotein, lipid (1, 14), and carbohydrate (34) moieties 
oflipoproteins have been studied but there is little information 
on the nature of the nascent lipid protein complexes in the 
various  organelles and  on  the  elapsed  time  of transfer of 
nascent  Apo  A-I  from  its  site  of synthesis  in  the  rough 
endoplasmic reticulum (RER) to the Golgi apparatus.  Re- 
cently  we  showed  that  newly  synthesized  Apo  A-I,  even 
though it is present within the RER and the smooth endo- 
plasmic reticulum,  failed to  float between densities  1.063- 
1.21 g/ml, whereas the Apo A-I, which is present within the 
Golgi complex, is capable of floating at a  buoyant density 
similar to that of plasma HDL (3). Using radioactive glycerol, 
we have further shown that although glycerol is quickly in- 
corporated into lipids of the endoplasmic reticulum and the 
Goigi cell fractions, the nascent lipids are mostly conjugated 
with Apo A-I in the Golgi apparatus (4). This indicates that 
most of the lipid-protein assembly occurs late in the secretory 
process, probably in the Golgi apparatus. 
In this report we describe the in vivo proteolytic processing 
of Apo  A-I,  by  measuring  the  NH2-terminal  amino  acid 
residues of nascent chicken apoprotein A-I in the RER, Golgi 
apparatus,  and  plasma;  and we show that,  compared with 
albumin, Apo A-I has a distinctive rapid transport time into 
the Golgi apparatus. 
MATERIALS  AND  METHODS 
Materials:  L-[5(n)-3H]arginine, L-[G-3H]glutamine,  L-[2,3-3H]proline, 
L-[5-aH]tryptophan,  L-[2,5AHlhistidine, L-[4-3H]phenylalanine, L-[2,3)H]as- 
partic acid, and L-[4,5-3H]leucine were obtained  from Amersham Corp., Ar- 
lington Heights, IL. Apotrinin (Trasylol) was purchased from Mobay Chemical 
Corp.,  NY;  phenylmethylsulfonyl  fluoride  (PMSF)  was  from Calbiochem- 
Behring Corp., La Jolla, CA; and N-tosyl-L-phenylalanine chloromethyl ketone 
(TPCK)  and  benzamidine  were from Sigma Chemical  Co.,  St.  Louis,  MO. 
Rabbit  immunogiobulin  monospecific  to chicken  serum albumin was pur- 
chased from Cappel Laboratories, CochranviUe, PA, and young leghorn chick- 
ens (5-10-d  old) were obtained from Spafas Poultry Farms, Norwich, CT. 
Preparation of Apo  A-I  and  Development  of Antibod- 
ies:  Blood was collected from the jugular vein of adult roosters and allowed 
to clot. The serum was separated from the clot and adjusted to 1 mM EDTA, 
pH 7.4, and  154 mM NaCI. HDL was floated from the adjusted serum between 
densities  1.063-1.21  g/ml, dialyzed  against 0.15  mM  NaCl,  0.01 M  sodium 
phosphate (pH 7.4) at 4"C and delipidated  as previously  described (3). Rabbit 
antiserum  to HDL apoproteins  was prepared  and tested for its specificity as 
previously described (4). This antiserum  was used to isolate nascent Apo A-I 
from the liver and serum. 
In Vivo Incorporation of Radioactive Amino Acid into Apo 
A-I:  Nascent  Apo  A-I  was  radiolabeled  in  vivo  by  injecting  individual 
radioactive amino acids into the jugular  veins of young chickens. At various 
times (from  3 to 60 min). the  livers were removed and blood was collected. 
The livers were rinsed throughly and homogenized in phosphate-buffered saline 
( I0 mM sodium phosphate buffer, pH 7.4, 154 mM NaC1) containing  100 ~g/ 
ml PMSF, 100 U/ml trasylol,  l  mM benzamidine,  and  l  mM TPCK.  When 
total intracellular Apo A-I was isolated, the homogenate was disrupted by the 
addition of 0.5% sodium deoxycholate and Triton  X-100 and a soluble super- 
natant  fraction was obtained by centrifuging at 105,000 g for 60 min. The Apo 
A-I or albumin present in this fraction was obtained by immunoprecipitation. 
To obtain  serum  Apo A-I, the  blood samples were allowed to clot in the 
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presence of 100 gg/ml PMSF, 100 U/ml Trasylol, 1 mM benzamidine, and  1 
mM TPCK for several hours at room temperature.  The serum was adjusted to 
10 mM sodium phosphate, pH 7.4, 154 mM NaC1, 0.5% sodium deoxycholate, 
0.5% Triton X-100, and secreted nascent APO A-I was isolated by immunopre- 
cipitation. 
Preparation  of RER  and  Golgi  Cell  Fractions:  Livers  were 
homogenized in 0.25 M sucrose, filtered through a layer of cbeese cloth, and a 
postmitochondrial  supernatant  was removed by centrifuging the homogenate 
at 16,000 g for 10 min. A total microsomal fraction was obtained by centrifuging 
the post mitochondrial  supernatant fraction at 105,000 g for 90 min. The RER 
and Golgi cell fractions were further separated and characterized as described 
earlier (4). 
Isolation of Radioactive Nascent Apo A-I and Albumin  from 
the  RER and Golgi  Complex  Fractions:  The cell  fractions  were 
treated  with 0.5% sodium  deoxycholate,  0.5% Triton  X-100  in  phosphate- 
buffered saline (10 mM sodium phosphate, pH 7.4, 154 mM NaCI, 100 ug/ml 
PMSF,  100  U/ml Trasylol,  l  mM benzamidine,  and  l  mM TPCK), and a 
detergent-soluble fraction was obtained  by centrifugation  at  105,000 g for 60 
min. The radioactive nascent APO A-I and albumin present in these fractions 
were recovered by immunoprecipitation  and in some experiments also by SDS 
PAGE. 
Immunoprecipitation of Albumin and Apo A-I:  Three equal 
aliquots, each containing  0.5-g tissue equivalent of detergent-soluble fractions 
prepared  from  either  liver homogenate  or isolated  organelles, or 0.1  ml of 
serum prepared as described above, were taken.  Each sample received one of 
the following: (a) 75 #1 of antiserum to rooster serum Apo A-I(I ml antiserum 
precipitated ~0.15  mg of Apo A-I); (b) 50 ul of antiserum  to chicken serum 
albumin  (1  ml antiserum  precipitated 0.3 mg of serum albumin); or (c) 75 ul 
of rabbit preimmune serum. All samples were incubated at 37"C for 60 rain, 
followed by 48 h at 4"C with gentle shaking. The antigen-antibody  precipitates 
were collected by centrifugation and washed several times with 0.02 M sodium 
phosphate buffer, pH 7.4, containing  154 mM NaCI, 100 ug/ml PMSF, 1 mM 
benzamidine,  1 mM TPCK,  and 100 U/ml Trasylol. The samples treated with 
preimmune rabbit serum did not contain a precipitate. The immune complex 
was either (a) suspended in 6 M urea,  1% SDS, and 2% ~3-mercaptoethanol in 
0.01 M Tris-phosphoric acid, pH 6.7, and heated in a boiling water bath for 2 
min prior to separation  of Apo A-I and/or albumin  on SDS PAGE, or (b) 
dissolved in 200-400  ul aldehyde-free 10% acetic acid. The first method  was 
used when measuring the  incorporation  of radioactive  leucine into  Apo A-I 
and albumin and the rate of transport of  these proteins from RER to the Golgi 
apparatus  whereas the second method  was applied when radioactive Apo A-I 
was prepared for amino acid sequencing. 
NH2-terminal Sequence Analysis of Intracellular and Se- 
creted Chicken Apo A-I:  Samples of immunopurifled  Apo A-I that 
were labeled in vivo by individual  radioactive amino acids were mixed with 
200 mg polybrene (Beckman Instruments,  Inc., Palo Alto, CA) and 50 nmol 
sperm whale apomyoglobin (Beckman Instruments,  Inc.) and subjected to 20 
cycles of automated  sequential  Edman degradation  using a  0.1  M Quadrol 
buffer program  in a Beckman 890D Sequencer (Beckman Instruments,  Inc.). 
The phenylthiohydantoin-derivatized  amino acids obtained at each cycle were 
dried  under N2  and  their  radioactivity  measured  in  presence  of  10  ml  of 
Betafluors (National Diagnostics, Inc., Somerville, N  J) using a Packard liquid 
scintillation counter.  The yield in each cycle was obtained by identifying and 
calculating the amount of amino acids recovered when standard apomyoglobin 
was used. The derivatized amino acids were separated by high pressure liquid 
chromatography using a CI8 Zorbax ODS column (DuPom Co., Wilmington, 
DE). 
Other Methods:  SDS PAGE was performed in  10% polyacrylamide 
slab gels containing  0.1% SOS using the gel and buffer system described by 
Laemmli (26). In some experiments, the radioactive proteins were detected by 
cutting the gels into 0.5-mm slices and determining radioactivity in the excised 
pieces. The slices were digested at 70-75"C in 0.4 ml 30% hydrogen peroxide 
and 0.2 ml of 60% perchloric acid for 2 to 4 hr. The samples were cooled at 
4"C and counted  in presence of 10 ml of Scintiverse Ii (Fisher Scientific Co., 
Fair Lawn, N  J) in a liquid scintillation spectrometer. Amino acid composition 
of Apo A-I was determined  in a  Beckman amino acid analyzer  6300 using 
ninhydrin  reaction program No.  1 (Beckman Instruments,  Inc.). 
RESULTS 
Time Course of Albumin and Apo A-I Secretion 
These initial experiments were designed to establish  and 
compare the time required for secretion of nascent albumin 
and Apo A-I. Both radioactive proteins appeared in the blood at about the same time (Fig. 1). In the first  15 min following 
the administration of L-[3H]leucine there was very little radio- 
active albumin or Apo A-I in the blood. After this initial  15- 
min period, both nascent albumin and Apo A-I entered the 
blood and continued to accumulate until 30 min. Radioactive 
albumin reached a maximal level in the blood by 45 min and 
radioactive Apo A-I by 30 min. 
Time of Intracellular Transport of Albumin and 
Apo A-I from RER to the Golgi Cell Fractions 
To determine whether nascent Apo A-I and albumin are 
transported at the same rate from site of synthesis on the RER 
to the Golgi apparatus, young chickens were administered L- 
[3H]leucine  intravenously and  at  different  times  the  livers 
were  removed,  fractionated  into  the  RER  and  Golgi  cell 
fractions,  and  the  time  taken  for radioactive albumin  and 
Apo A-I to appear in these  cell fractions were measured. At 
given times,  the amounts of both albumin and Apo A-I were 
measured in the same animal. Pulse-labeled  albumin reached 
maximal amounts in the RER between 3 and 9 min after the 
administration of L-[aH]leucine and between 9 and 25 min in 
the Golgi apparatus (Fig. 2A). By contrast, maximal Apo A-I 
radioactivity occurred at the same time (from 3 to 15 min) in 
both the RER and the Golgi cell fractions (Fig. 2B). There is 
an indication, at 3 min, that APO A-I first enters the RER, 
but it also appears very rapidly in the Golgi cell fraction. The 
amounts of radioactive Apo A-I present in the RER and the 
Golgi cell fraction at 15 min suggests that Apo A-I is cleared 
from the RER before it is emptied from Golgi vesicles. These 
experiments indicate that although albumin and Apo A-I are 
secreted  into the blood at similar rates (Fig.  1), nascent APO 
A-I undergoes a much more rapid transport from the RER to 
the Golgi apparatus than does albumin. 
Amino Acid Composition  and NH2-Terminal of 
Serum Apo A-I Obtained from Young Chickens 
Because  the NH2-terminal amino acid sequence of serum 
Apo A-I, obtained from young chickens,  has been reported to 
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FIGURE  1  Time course of nascent Apo A-I and albumin secretion 
by chicken liver. Young chickens were injected intravenously with 
L-[4,5-BH]leucine.  At  specified  times,  the  birds  were  killed  and 
blood was collected. Radioactive Apo A-I and albumin were isolated 
from  the  serum  by  immunoprecipitation  as  detailed  in  Materials 
and Methods. The closed circles indicate the radioactivity in newly 
secreted Apo A-I and open circles that of albumin. 
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FIGURE  2  Time of intracellular transport of albumin and Apo A-I 
from  RER to the Golgi apparatus.  Young chickens were injected 
with L-[4,5-3H]leucine  and at specified times the livers  were re- 
moved and fractionated into RER and Golgi cell fractions.  Radio- 
active Apo A-I and albumin were obtained by immunoprecipitation 
as described in  Materials and Methods. The values given are the 
average of three experiments. A  shows the albumin radioactivity 
while B shows that of Apo A-I. O, RER; II, Golgi cell fractions. 
be different  from that obtained from hens (2 l, 32), we isolated 
ADo A-I from young chicken serum  HDL,  determined  its 
amino acid composition and the amino acid sequence of 20 
NH2-terminal residues,  and compared it to that of Apo A-I 
obtained from hen, rooster, and human serums. Apo A-I from 
the  serum  of young chickens  contained  248  amino  acid 
residues per mol and the overall amino acid composition was 
very similar  to that of hen (21), rooster (25), and human (2) 
Apo A-I with a few exceptions (Table  I). There are only six 
residues  of serine  as compared to  13 for hen,  10 for rooster, 
and  14 for human Apo A-I. Young chicken serum Apo A-I 
also appeared to contain slightly higher amounts of glycine, 
which  may  be  due  to  the  fact  that  in  the  final  stage  of 
purification of Apo A-I by SDS PAGE, a glycine buffer was 
used. 
Twenty cycles of automated Edman degradation of young 
chicken serum Apo A-I revealed the following amino terminal 
sequence: D.E.P.Q.T.P.L.D.R.I.R.D.M.V.D.V.T.LE.T. 2  (Ta- 
ble  II).  This  amino-terminal  sequence  is  identical  to  that 
previously  reported  by  Shackelford  and  Lebherz  (32)  for 
chickens and  differs  from that  of Apo A-I  from hen  and 
humans. The reported NH2-terminal sequences for hen serum 
Apo A-I is D.E.P.Q.P.E.L (21) and for human serum APO A- 
I is D.E.P.P.Q.S.P.  (6). 
2  In this paper a one-letter notation for Amino Acid Sequences as 
recommended by IUPAC-IUB  Commission on Biochemical Nomen- 
clature (J. Biol. Chem., 1968, 243:3557-3559) is used. 
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from the Serum of Young Chicken, Hen, Rooster, and Human 
Young  Hen  Rooster  Human 
Amino acids  chicken  (21)  (25)  (2) 
Aspartic acid  21  20  20  21 
Threonine  9  12  11  10 
Serine  6  13  10  14 
Glutamic acid  50  50  47  47 
Proline  10  8  12  10 
Glycine  17  5  3  10 
Alanine  22  21  23  19 
Valine  13  13  13  13 
Methionine  5  4  5  4 
Isoleucine  5  5  6  ND 
Leucine  33  33  33  39 
Tyrosine  6  5  7  7 
Phenylalanine  6  4  5  6 
Lysine  23  20  21  21 
Histidine  1  1  1  5 
Arginine  21  16  18  16 
Tryptophan  N D  4  1  4 
Half-cystine  ND  ND  ND  ND 
Total  248  234  236  246 
Molecular weight  27,000  26,674  26,000  28,331 
The results, expressed as residues per mol, are averages  of duplicate analyses 
of at least two different samples assuming a molecular weight of 27,000. 
TABLE II.  Amino-Terminal  Sequence  Analysis of Young Chicken 
Serum Apoprotein A-I 
Sequenator 
cycle no.  PTH* amino acid identified  Yield 
(ritual) 
1  Aspartic acid  22.6 
2  Glutamic acid  20.8 
3  Proline  2.4 
4  Glutamine  32.7 
5  Threonine  7.4 
6  Proline  3.6 
7  Leucine  3.9 
8  Aspartic acid  21.7 
9  Arginine  22.4 
10  Isoleucine  5.1 
11  Arginine  22.7 
12  Aspartic acid  11.1 
13  Methionine  8.0 
14  Valine  3.6 
15  Aspartic acid  7.9 
16  Valine  2.6 
17  Tyrosine  1.58 
18  Leucine  5.0 
19  Glutamic acid  12.8 
20  Threonine  2.66 
Approximately 225 #g lyophilized Apo A-I  was dissolved  in  10% glacial 
acetic  acid  and  subjected  to automated Edman degradation  analysis as 
described  in Materials and Methods. The PTH-amino acid residues were 
identified by high pressure liquid chromatography. 
* PTH, phenylthiohydantoin. 
Amino-Terminal Sequence of Nascent 
Intracellular and Secreted Apo A-I 
Aspartic  acid  and  proline  occur  at  the  amino-terminal 
portion of both chicken and human Apo A-I and we suspected 
that the pro-segment of chicken Apo A-I may be similar to 
that  of the pro-segment of human Apo  A-I.  Therefore,  in 
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order to determine whether or not the pro-segment of chicken 
Apo A-I is homologous to that of human Apo A-I and whether 
it is processed intracellularly, we administered to young birds, 
individually in separate experiments, the radioactive form of 
each of the amino acids present in the pro-segment of human 
Apo A-I, and of aspartic acid and proline. After 30 rain, the 
blood and livers were collected and the radioactive Apo A-I 
present within the liver and that secreted into the blood was 
obtained by immunoprecipitation. The immunoprecipitates 
were subjected to twenty cycles of automated Edman degra- 
dation and the radioactivity in each cycle determined.  The 
radioactive  profile  obtained  in  each  cycle  for  the  various 
radioactive amino acids used is shown in Fig.  3. 
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FIGURE  3  Radioactive amino acid  sequence  of  intracellular and 
secreted Apo A-I. Young chickens were injected intravenously with 
the following individual radiolabeled amino acids; L-[5(n)-3H]argi - 
nine,  L-[2,5-3H]histidine,  L-[4-3H]phenylalanine,  L-[5-3H]trypto  - 
phan,  L-[G-3H]glutamine,  L-[2,3-~H]aspartic  acid,  and  L-[2,3-~H] - 
proline.  After  30  min,  the  blood  and  livers  were  collected  and 
radioactive Apo A-I  present either intracellularly or  in the  serum 
was obtained by immunoprecipitation as described under Materials 
and Methods. To the isolated intracellular and secreted Apo A-I,  1 
mg of sperm whale apomyoglobin was added and the samples were 
subjected to automated amino acid sequencing. The radioactivity 
in various cycle numbers  is shown. The  pertinent cycle numbers 
are given  above the  radioactive  peaks.  On  the  left  side  (A)  the 
radioactive patterns obtained from intracellular Apo A-I are shown. 
On the.right side (B) the radioactive patterns obtained from secreted 
Apo A-I  are given. The cycle numbers  in A  are underlined when 
radioactivity would  be  expected  if  unprocessed  pro-Apo  A-t  is 
present. Intracellular radioactive Apo  A-I  contained two  amino- 
terminal residues, arginine and aspartic acid, suggesting that 
it is a mixture of  processed Apo A-I (containing NH2-terminal 
aspartic acid) and of another form of Apo A-I,  with NH2- 
terminal arginine (Fig. 3A). Having determined the sequence 
of 20 NH2-terminal amino acids of serum (processed)Apo A- 
I (Table II), any additional amino acids found in these posi- 
tions should be due to the presence of pro-Apo A-I. Therefore 
the occurrence of arginine in cycles l, 15, and 17, of histidine 
in cycle 2, of phenylalanine in cycle 3, or tryptophan in cycle 
4, ofglutamine in cycles 5, 6, and 10, ofaspartic acid in cycles 
7,  14, and 18, and of proline in cycles 9 and 12 indicates the 
following pro-hexapeptide extension: R.H.F.W.Q.Q. The oc- 
currence of arginine in cycles 9 and 11, ofglutamine in cycle 
4, of aspartic acid in cycles I, 8, 12, and 15, and ofproline in 
cycles  3  and  6  identifies the  other  radioactive protein  as 
processed APO A-I since this assignment is identical to that 
obtained when serum Apo A-I was sequenced (Table II). NH2- 
terminal sequence analysis of the secreted radioactive protein 
obtained from blood showed radioactive arginine in cycles 9 
and 10, glutamine in cycle 4, aspartic acid in cycles 1, 8,  12, 
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FIGURE 4  NHz-terminal amino acid sequence of intracellular pro- 
Apo A-I and secreted  serum Apo A-I.  The figure  is based on the 
amino acid sequence of the amino-terminal portion of nascent Apo 
A-I obtained from the RER, Golgi cell fractions,  and serum (Fig. 3 
and 5). The arrow (~) indicates the processing site of pro-Apo A-I 
to Apo A-I. 
and 15, and proline in cycles 3 and 6 (Fig. 3 B). This indicates 
that nascent Apo A-I in serum has the following NH2-terminal 
sequence: D.w.P.Q.--.P.--.D.R.--.R.D.--.--.D.----.  This 
sequence is identical to that of serum Apo A-I (Table II) and 
indicates that the processing is complete by the 30-min time 
point. A summary of the NH2-terminal sequences of intracel- 
lular and secreted Apo A-I is presented in Fig. 4. 
Cellular Sites of Processing of Pro-Apo A-I 
To determine whether the processing of radioactive pro- 
Apo A-I occurs within the endoplasmic reticulum or the Golgi 
apparatus, young chickens were administered L-[2,3-3H]pro - 
line (present in NH2-terminal residues 3 and 6 of processed 
Apo A-I) or L-[G-aH]glutamine (present in residues 5 and 6 
of the pro-segment and in residue 4 of processed Apo A-I), 
and after 10 to 15 min the livers were fractionated into RER 
and Golgi cell fractions. Radioactive APO A-I was isolated by 
immunoprecipitation from detergent-soluble RER and Golgi 
cell fractions and subjected to 20 cycles of automated amino 
acid sequence analysis.  The results are given in Fig. 5. In the 
RER, glutamine radioactivity was found in cycles 5, 6, and 
10 (Fig. 5A, upper panel), whereas in the Golgi cell fractions 
radioactive glutamine was present in cycles 5, 6, and 10 and 
also in cycle 4 (Fig. 5B, upper panel). 
Proline radioactivity was found in cycles 9 and 12 for Apo 
A-I  isolated from the RER  (Fig.  5A,  lower panel)  and  in 
cycles 3, 6, 9, and  12 for Apo A-I obtained from the Golgi 
apparatus (Fig. 5 B, lower panel). This indicates that nascent 
Apo A-I in the Golgi region is a mixture of pro-Apo A-I and 
APO A-I, whereas nascent pro-Apo A-I is the only Apo A-I 
form present in the RER. 
Based on the amount of  radioactivity in Edman degradation 
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FIGURE 5  Location of L-[2,3-3H]proline  and L-[G-3H]glutamine residues in Apo A-I obtained from the RER and Golgi cell fractions. 
Chickens were administered L-[3H]proline  or t-[3H]glutamine for 10 to 15 min to label intracellular Apo A-I as described  in Fig. 
3. The RER and Golgi cell fractions from 28 g of liver were pooled and ruptured to release their contents as described in Materials 
and Methods. Radioactive nascent Apo A-I was isolated both from the RER and the Golgi contents by immunoprecipitation and 
subjected  to automated amino acid sequencing as described in Fig. 3. Top panel shows the radioactive pattern obtained from 
Apo A-I labeled with L-[3H]glutamine and bottom panel that with L-[3H]proline.  On the left hand side are the materials obtained 
from the RER and on the right hand side that from the Golgi cell fractions. The radioactive peaks are marked with the pertinent 
cycle numbers. The cycle numbers underlined are those in which radioactivity would be expected if unprocessed pro-Apo A-I is 
present. 
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Total* intra-  Golgi 
cellular  RER*  apparatus  t  Serum* 
Percent radioactivity 
Pro-Apo-A-I  43.5 _  12.8  100  49 +  4.9  0 
Apo-A-I  56.5 4- 12.8  0  51  4- 4.9  100 
Individual radioactive amino acids were injected intravenously and at either 
10 to 15 min (RER and  Golgi apparatus)  or 30 min (total  intrace~lular and 
serum)  nascent  Apo A-I  was isolated  from  the various  cell  fractions  by 
immunoprecipitation and subjected to automated amino acid sequencing. 
The  percent of pro-Apo A-I  and  Apo A-I was calculated from the yield 
obtained from the internal  apomyoglobin standard and from the amount of 
radioactivity in each cycle when informative radiolabeled amino acids were 
used (Figs. 3 and 5). 
* Calculations  based on the averages from four different radioactive amino 
acids. 
* Based on two experiments with different radioactive amino acids. 
cycles which are distinctive for either pro-Apo A-I or for fully 
processed Apo A-I, and taking into account the recovery of 
derivatized amino acids  (when  using  sperm whale  apomy- 
oglobin), the percent of pro-Apo A-I and processed Apo A-I 
in each sample was calculated. Intracellularly in the total liver 
56.5% of pro-Apo A-I is processed to Apo A-I and a similar 
ratio (49%, pro-Apo A-I; 51% Apo A-I) was obtained in the 
Golgi cell fractions. By contrast, nascent Apo A-I in the RER 
is  100% in the pro-Apo A-I form; and in the serum 30 min 
after the administration of radioactive amino acid,  100% of 
the nascent Apo A-! is fully processed (Table III). 
DISCUSSION 
Since  1971,  when  Morgan  and  Peters  studied  the  in  vivo 
secretion of albumin and transferrin, it has been known that 
hepatic  proteins  travel  through  the  intracellular  secretory 
pathway at different rates (31). This variation in intracellular 
transit time is reflected in different secretion times for hepatic 
plasma proteins (27). The translocation of secretory proteins, 
from site of synthesis on the RER to the Golgi apparatus, is 
the step in which most variations occurs and this has led to 
the  suggestion that  receptors in  the endoplasmic reticulum 
membrane select and regulate the transport of protein from 
the endoplasmic reticulum to the Golgi apparatus (29). Thus 
it is not surprising that nascent Apo A-I travels to the Golgi 
apparatus at a different rate than albumin. What is of interest 
however is the quickness with which Apo A-I enters the Golgi 
fractions and the length of time it is retained within Golgi 
apparatus-derived vesicles prior to secretion into the blood. 
Studies  which  have measured the  rate  of entry  of nascent 
secretory  hepatic  proteins  into  the  Golgi  apparatus  have 
shown that albumin usually leads and other proteins such as 
a 1-antichymotrypsin and transferrin follow at a  slower rate 
(29). The secretion of Apo A-I differs in that its transfer from 
RER to Golgi cell fraction is so rapid that it is difficult, by in 
vivo  pulse-labeling  methods,  to  measure  its  rate.  Peak 
amounts of Apo A-I radioactivity are noticed in the RER and 
the Golgi cell fractions at the same time (between 3 and  15 
min) and there is only a slight indication, at the earliest time 
points (3 min) that Apo A-I has entered the RER prior to the 
Golgi cell fraction (Fig.  2). By contrast, in the same animal, 
the  stepwise progression of nascent albumin  from RER to 
Golgi apparatus is clearly apparent. If albumin and Apo A-I 
are synthesized in similar locations on the RER and we accept 
the hypothesis that small carrier vesicles bud from the endo- 
plasmic reticulum and carry the nascent proteins to the Golgi 
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apparatus (29),  then our results imply that vesicles carrying 
nascent Apo A-I are immediately formed and transported to 
the Golgi region.  Alternatively, the  polysomes synthesizing 
Apo A-I may be located in specialized regions of the cyto- 
plasm,  in  close juxtaposition  to  the  Golgi  apparatus,  thus 
allowing faster translocation. Membrane-attached polysomes 
have been  noticed  close to  Golgi  apparatus (10).  Another 
possibility is that, at the early time following pulse labeling, 
Apo A-I is not present in the Golgi apparatus but in some 
other cellular sub-fraction that co-fractionates with the Golgi 
cell  fractions. This is unlikely, since the Golgi cell  fractions 
(described in references 3 and 4) are devoid of RER vesicles. 
If the pulse-labeled Apo A-I is present in a  vesicle  which is 
not derived from the Golgi apparatus, it would have to be a 
specialized  smooth  endoplasmic  reticulum  compartment 
which does not contain nascent albumin, such as the postu- 
lated carrier vesicles which travel from the endoplasmic retic- 
ulum to the Golgi apparatus. 
Our previous studies showed that nascent Apo A-I in the 
RER contain very little lipid and that most of the assembly 
of Apo A-I into lipoproteins occurs in the Golgi cell fraction 
(4).  What determines when and how lipid-protein conjuga- 
tion occurs is not known, but a mechanism must exist in the 
endoplasmic reticulum to protect nascent Apo A-I from bind- 
ing to or from being inserted permanently into existing lipid 
particles. There may be a need, therefore, for Apo A-I to be 
quickly segregated within the endoplasmic reticulum and the 
haste by which it is transported to the Golgi apparatus may 
be in order to position it in the locale at which proper lipid- 
protein  interactions  may  occur.  The  rapidity  with  which 
nascent Apo A-I enters the Golgi cell fraction is reminiscent 
of the  rate at which pulse-labeled total membrane proteins 
enter this fraction (30). 
Studies with rats and humans, using both liver and intestine, 
with either perfused tissues, organs, or cell culture, have shown 
that pro-Apo A-I is secreted into the blood and is then later 
processed, by the removal of an NH2-terminal hexapeptide, 
to Apo A-I (9,  12,  13,  15,  38,  41).  In young chickens the 
secretion of Apo A-I is clearly different. Pro-Apo A-I is the 
only form present in the RER, a near equal mixture of pro- 
Apo A-I and Apo A-I is found in the Golgi cell fraction, and 
100%  of the  newly  secreted  apolipoprotein  present  in  the 
serum is processed Apo A-1. These results may be interpreted 
in several ways. Young chickens may begin to process pro- 
Apo A-I to Apo A-I in the Golgi cell fraction and the proc- 
essing is completed prior to secretion. In this case only proc- 
essed Apo A-I is secreted into the blood. Another possibility 
is that, since there is a mixture of pro-Apo A-I and Apo A-I 
in the Golgi fraction, this mixture is secreted and pro-Apo A- 
I is then immediately converted by an extracellular enzyme 
to Apo A-I. We do not detect, however, at 30 min of secretion, 
any pro-Apo A-I in the circulating blood. A third possibility 
is that there is no processing intracellularly and that blood 
enzymes, present in  the  liver during  homogenization  may 
account for the presence of intracellular processed Apo A-I. 
It is  unlikely  however that  these  processing  enzymes will 
penetrate the Golgi vesicles and not enter the vesicles derived 
from the RER. However we can not rule out the possibility 
that pro-Apo A-I is sequestered in the RER differently than 
in the Golgi apparatus or is in a conformation unfavorable to 
processing. A fourth possibility is that processing occurs ex- 
traceUularly and that nascent Apo A-I is rapidly endocytosed 
by the liver. The method used in this study for preparation of Golgi  cell  fractions  has been  shown to  contain  endosomes 
(24), and these endosomes could provide the 51% radioactive 
processed Apo A-I found in the Golgi cell fraction.  This latter 
possibility is considered unlikely since the amount of process- 
ing in the Golgi cell fraction  was measured between  10 and 
15 min after the administration of radioactive  amino acids, 
and at that  time there was little  or no radioactive Apo A-I 
secreted into the blood (see Fig.  1). The most likely possibility 
is that processing begins in the Golgi cell fraction and contin- 
ues to occur in the terminal events of secretion.  A  metallo- 
enzyme which converts human pro-Apo A-I to Apo A-I has 
been detected in plasma HDL, in mesenteric lymph, and in 
lymph chylomicrons (9). The source and exact nature of this 
extracellular  enzyme have not been determined and we do 
not  know whether  or  not  a  similar  enzyme  is  present  in 
chickens.  The  facts  that  the  processing  enzyme  has  been 
detected in lipoprotein particles and that, in chicken, process- 
ing occurs intracellularly  in a Golgi cell fraction  suggests that 
the processing enzyme could be a part of nascent HDL. The 
processing enzyme may be inserted  into HDL during assem- 
bly and processing may occur at any subsequent stage of HDL 
secretion.  This would be different  to the processing of other 
secretory  pro-proteins whose  point  of cleavage  are  usually 
marked by arginine  residues.  In these latter cases the process- 
ing enzyme is thought to reside in the Golgi membrane (36). 
Paired glutamine residues, at the site of proteolytic process- 
ing,  are  not unique to  pro-Apo A-I.  The initial  translation 
product of tropoelastin b mRNA contains a  24 amino acid 
NH2-terminal peptide which, like the prosegment of Apo A- 
I,  contains a gin-gin  dipeptide at its carboxyterminus (23). 
Tropoelastin b,  a  major component of connective tissue,  is 
an extracellular  protein.  It is not known, however, whether 
the  paired  giutamine  residues  mark the  cleavage  sites  of a 
signal  or  a  pro-sequence.  If the  paired  glutamine  residues 
mark the end of the signal sequence, then it could be assumed 
that cleavage occurs co-translationally.  If, however, tropoelas- 
tin b also contains a prosegment, which is marked by the two 
giutamine residues,  then cleavage may be either intracellular, 
as in chicken Apo A-I, or extracellular,  as in rat and human 
Apo A-I. 
Our  studies show  that  the  prosegments of chicken  and 
human  Apo  A-I  are  both  six  amino  acids  in  length  with 
identical  sequences  including  a  pair  of glutamines  at  the 
carboxy-terminal end. In addition, the NH2-terminal  portions 
of processed Apo A-I are similar, both commencing with asp. 
giu.  pro...residues.  Yet the pro-Apo A-I  in  human and rat, 
which presumably also travels  through the Golgi apparatus, 
is  not  cleaved  intracellularly  to  Apo  A-I  whereas  that  of 
chicken is processed.  That pro-Apo A-I may be cleaved intra- 
cellularly  in  one species  and  not in  another,  and  yet both 
have  identical  prosegments,  is  puzzling.  The  difference  in 
processing between human, rat, and chicken may be a species 
difference,  may be due to a difference  in the mode of action 
of the processing enzyme, or may be due to the fact that only 
in chicken has processing been measured in vivo while in the 
human and  rat, organ and cell  culture methods have been 
used. 
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